With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular, are not ...
hbctraining/Shell-for-bioinformatics’s past year of commit activity ...
LIMASSOL, Cyprus--(BUSINESS WIRE)--B2BROKER, a liquidity and technology solutions provider for Forex and crypto markets, has released the 17th major update to its flagship CRM platform, B2CORE ...
The presence of antibodies without viral antigen or DNA. The presence of IgG anti-HBcAb but lack of IgM anti-HBcAb antibody (in our case, we tested for IgG only. Given the predominance of IgG in ...
Department of Thoracic Oncology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The second Affiliated Hospital of Nanchang Medical College, Nanchang, China ...
Inspector General of Government (IGG) Beti Kamya Sunday decried persistent corruption as the ruling National Resistance Movement (NRM) party marked 39 years of Museveni’s presidency. According ...
HBV reactivation (HBVr) occurs when HBV activity is no longer suppressed by the immune system in people who are either positive for the HBV surface antigen (HBsAg) or HBV core antibody (anti-HBc).
Hippler also heard arguments about whether specific evidence – including investigative genetic genealogy or IGG – should be admitted at trial Thursday. Due to the nature of the arguments and ...
BOISE, Idaho — Bryan Kohberger, the man accused of murdering four University of Idaho students, was in court Thursday as a two-day hearing regarding DNA evidence got underway. 4th District Judge ...
It should include a "triple" panel of HBsAg, antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr. AGA's guidance is based ...
It should include a “triple” panel of HBsAg, antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr. AGA’s guidance is b ...
In this paper, the authors present an interesting strategy to interfere with the HBV life cycle: the preparation of geranyl and peptides' dimers that could impede the correct assembly of hepatitis B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results